Dose optimization of MO-2097, a novel chiral-free HIF-1α inhibitor, against BALB/c mice xenograft model using MATLAB-based integrated pharmacokinetics-pharmacodynamics (PK-PD) modelopen access

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.